ArticlePloS one2024

Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam.

Anh Quynh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.